Omnicell OMCL
NASDAQ OMCL
$34.37 -0.45 (-1.29%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omnicell (OMCL) Cash from Operations (2010 - 2026)

Omnicell's (OMCL) quarterly Cash from Operations came in at $68.3 million in Q2 2026, up 59.78% year-over-year from $42.8 million in Q2 2025, and up 25.35% quarter-over-quarter from $54.5 million in Q1 2026.

Analysis

Omnicell (OMCL) Cash from Operations (2010 - 2026) Analysis & Trends

Omnicell (OMCL) has reported Cash from Operations for 17 consecutive years, with $68.3 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash from Operations rose 59.78% year-over-year to $68.3 million in Q2 2026; TTM through Jun 2026 was $181.4 million, a 22.8% increase from a year earlier, with the FY2025 full-year figure at $127.3 million, down 32.19% from the prior year.
  • Cash from Operations was $68.3 million for Q2 2026 at Omnicell, up from $54.5 million in the prior quarter.
  • Over five years, Cash from Operations peaked at $82.2 million in Q4 2022 and troughed at -$16.0 million in Q1 2022.
  • A 5-year average of $38.7 million and a median of $40.6 million in 2023 frame the typical range for Cash from Operations.
  • Across the five-year window, Cash from Operations plunged 127.86% in 2022 and soared 863.3% in 2023, its largest moves.
  • Over 5 years, Cash from Operations stood at $82.2 million in 2022, then slumped by 53.24% to $38.4 million in 2023, then surged by 46.6% to $56.3 million in 2024, then plunged by 46.1% to $30.4 million in 2025, then surged by 125.06% to $68.3 million in 2026.
  • The last three Cash from Operations figures came in at $68.3 million (Q2 2026), $54.5 million (Q1 2026), and $30.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 2.49 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 1.06 Bn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 1.79 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 1.26 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 1.47 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 651.90 Mn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn 510.00 Mn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 269.20 Mn
9 Resmed 32.94 Bn 31.47 Bn 861.22 Mn 454.63 Mn
10 Omnicell 1.57 Bn 1.28 Bn 152.94 Mn 68.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 68.31 Mn
Mar 31, 2026 54.50 Mn
Dec 31, 2025 30.35 Mn
Sep 30, 2025 28.27 Mn
Jun 30, 2025 42.76 Mn
Mar 31, 2025 25.92 Mn
Dec 31, 2024 56.32 Mn
Sep 30, 2024 22.75 Mn
Jun 30, 2024 58.70 Mn
Mar 31, 2024 49.95 Mn
Dec 31, 2023 38.41 Mn
Sep 30, 2023 57.01 Mn
Jun 30, 2023 72.90 Mn
Mar 31, 2023 12.77 Mn
Dec 31, 2022 82.15 Mn
Sep 30, 2022 21.18 Mn
Jun 30, 2022 -9.55 Mn
Mar 31, 2022 -16.00 Mn
Dec 31, 2021 59.63 Mn
Sep 30, 2021 42.99 Mn